Drug Discovery
NVIDIA's NIM Agent Blueprint Transforms Drug Discovery with AI-Driven Virtual Screening
NVIDIA's NIM Agent Blueprint leverages generative AI for faster, cost-effective drug discovery, enhancing hit-to-lead transitions.
Drug Discovery
Recursion CEO Chris Gibson Discusses AI's Role in Revolutionizing Biopharma
Recursion's CEO Chris Gibson explains how AI and machine learning are accelerating drug discovery and development in the biopharmaceutical industry.
Drug Discovery
AI-Driven Molecular De-Extinction: A New Frontier in Combating Drug-Resistant Pathogens
Researchers are using AI to resurrect DNA from extinct species to combat drug-resistant pathogens, potentially revolutionizing antibiotic discovery.
Drug Discovery
Quantum Mechanics Bolsters Drug Discovery with QUELO-G and CUDA Graphs
Quantum mechanics is enhancing drug discovery through the use of QUELO-G and CUDA graphs.